Case report and review of minocycline-induced cutaneous polyarteritis nodosa

Arthritis Care and Research

Volumn 53, Issue 3, 2005, Pages 468-470

  Culver, Brent ^a,b   Itkin, Aleksandr ^a   Pischel, Ken ^a  

^a SCRIPPS CLINIC   (United States)

^b MS113 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; ORAL CONTRACEPTIVE AGENT; PREDNISONE;

ACNE; ADULT; ALOPECIA; ANAMNESIS; ANKLE EDEMA; ANKLE PAIN; ARTHRITIS; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; ERYTHEMA NODOSUM; FATIGUE; FEMALE; FEVER; HUMAN; HYALINE DEGENERATION; JOINT STIFFNESS; LIVEDO RETICULARIS; LUPUS ERYTHEMATOSUS; MOUTH ULCER; MYALGIA; NECROTIZING ARTERITIS; PANNICULITIS; PERIPHERAL NEUROPATHY; POLYARTERITIS NODOSA; RASH; REVIEW; SKIN GRANULOMA; SKIN MANIFESTATION; SKIN NODULE; SUBCUTANEOUS NODULE; THROMBOSIS; VASCULITIS;

ACNE VULGARIS; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MINOCYCLINE; POLYARTERITIS NODOSA; SKIN DISEASES;

EID: 20444379300     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21186     Document Type: Review

References (16)

1. Elkayam O, Yaron M, Caspi D. Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 1999;28:392-7.
2. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999;111:507-13.
3. Bajema IM, Hagen EC. Evolving concepts about the role of antineutrophil cytoplasm autoantibodies in systemic vasculitides. Curr Opin Rheumatol 1999;11:34-40.
4. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998;41:1521-37.
5. Ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 2002;36:130-47.
6. Borrie P. Cutaneous polyarteritis nodosa. Br J Dermatol 1972;87:87-95.
7. Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol 1997;136:706-13.
8. Kallenberg CG, Mulder AH, Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992;93:675-82.
9. Schrodt BJ, Callen JP. Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics 1999;103:503-4.
10. Schaffer JV, Davidson DM, McNiff JM, Bolognia JL. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 2001;44:198-206.
11. Pelletier F, Puzenat E, Blanc D, Faivre B, Humbert P, Aubin F. Minocycline-induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies. Eur J Dermatol 2003;13:396-8.
12. Saka H, Komatsu S, Matsuo S, Iizuka A. Two cases of minocycline-induced vasculitis. Arerugi 2002;51:1153-8.
13. Elkayam O, Yaron M, Caspi D. Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA. Ann Rheum Dis 1996;55:769-71.
14. Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, et al. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med 1998;105:484-7.
15. Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus: a systematic review. Dermatology 2000;200:223-31.
16. Dunphy J, Oliver M, Rands AL, Lovell CR, McHugh NJ. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 2000;142:461-7.